Trials / Completed
CompletedNCT00002352
A Study of Lobucavir in Patients With AIDS
Pilot Study of the Antiviral Activity of Multiple Doses of Oral Lobucavir in AIDS Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (planned)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to see if lobucavir is a safe and effective treatment for cytomegalovirus in patients with AIDS.
Detailed description
Patients receive 1 of 2 doses of lobucavir for 28 days, with 2 weeks of follow-up. Weekly clinic visits are required.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lobucavir |
Timeline
- First posted
- 2001-08-31
- Last updated
- 2007-10-02
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00002352. Inclusion in this directory is not an endorsement.